Top 19 Vestagen Technical Textiles investors
The most complete profiles first. Showing 19 of 19.
David KabakoffVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareCybersecurityMessagingWellnessPortfolio: Magnolia Medical Technologies, Avizia, RareCyte, inMediata and 22 more
Verified email available
Garheng KongVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareCybersecurityMessagingWellnessPortfolio: Magnolia Medical Technologies, Avizia, RareCyte, inMediata and 20 more
Verified email available
Jared TeoVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareCybersecurityMessagingWellnessPortfolio: Magnolia Medical Technologies, Avizia, RareCyte, inMediata and 20 more
Contact details available
Jonathan LeffVerified
Venture Capital, Investor · United States
SeedSeries BHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more
Verified email available
Sarah BhagatVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Alan ColowickVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Jason PittsVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Mike PowellVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Maha Katabi, PhD, CFA
Hedge Fund, Venture Capital, Investor · Canada
SeedHealth CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more
Contact details available
Perry Nisen
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Todd Creech
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareCybersecurityMessagingWellnessPortfolio: Magnolia Medical Technologies, Avizia, RareCyte, inMediata and 20 more
Contact details available
Victoria Lai
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareCybersecurityMessagingWellnessPortfolio: Magnolia Medical Technologies, Avizia, RareCyte, inMediata and 20 more
Contact details available
Alfred Yue
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Hooman Shahlavi
Hedge Fund, Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Trit Garg
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWellnessPortfolio: Magnolia Medical Technologies, Avizia, RareCyte, inMediata and 20 more
Contact details available
Fred KochVerified
Venture Capital · United States
Health CareCybersecurityCommunity DevelopmentNews MediaPortfolio: BodeTree, Vestagen Technical Textiles, MyForce
Verified email available
Patrick VaheyVerified
Venture Capital · United States
Health CareCybersecurityInvestment ManagementCommunity DevelopmentPortfolio: BodeTree, Vestagen Technical Textiles, MyForce
Verified email available
Randy KahnVerified
Venture Capital · United States
Health CareCybersecurityCommunity DevelopmentNews MediaPortfolio: BodeTree, Vestagen Technical Textiles, MyForce
Contact details available
Kermit Billups
Venture Capital · United States
Health CareCybersecurityCommunity DevelopmentNews MediaPortfolio: BodeTree, Vestagen Technical Textiles, MyForce
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- First Aid Shot Therapy15
- Dauntless Pharmaceuticals10
- Guavus9
- Principia Biopharma9
- LYSOGENE9
- NuCana9
- Checkmate Pharmaceuticals9
- Y-mAbs Therapeutics9
- VelosBio9
- ConteXtream9
- Histogenics9
Frequently asked questions
How many Vestagen Technical Textiles investors are on Angel Roster?
Angel Roster lists 19 Vestagen Technical Textiles investors. 9 of them (47%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (19), Private Equity Firms (6) and Hedge Funds (2). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Vestagen Technical Textiles investors invest in?
Among those that list a stage, the most common are Series B (5) and Seed (5).
Where are Vestagen Technical Textiles investors based?
Most are based in the United States (18) and Canada (1).
Which companies have Vestagen Technical Textiles investors backed?
The most-backed portfolio companies among them are First Aid Shot Therapy (15), Dauntless Pharmaceuticals (10), Guavus (9), Principia Biopharma (9) and LYSOGENE (9).
How do I contact Vestagen Technical Textiles investors?
Create a free Angel Roster account to search and filter all 19, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.